In a new study from McMaster University, researchers found that trained immune cells that ruthlessly kill cancerous tumors may prove a game-changer for people living with late-stage cancer.
They uncovered that changing the metabolism of natural killer (NK) immune cells allows these cells to overcome the hostile conditions found inside tumors and destroy advanced ovarian and lung cancer.
In the past decade, cancer immunotherapy has achieved tremendous effects in patients with blood cancers.
However, the immunosuppressive conditions found inside solid tumors, whose aggressive growth starves surrounding healthy tissues of energy, have until now remained a formidable barrier for immune cell therapies.
In this study, the team discovered that the metabolism, or energy ‘hub,’ of NK cells is paralyzed by tumors, causing the NK cells to undergo an energy crisis and lose their tumor-killing functions.
With that understanding, they were able to reverse the dysfunction of NK cells by repurposing a pre-existing metabolism drug that restored their energy production.
While these findings answered the decades-old question of how it is that NK cells are suppressed by tumors, the study has another major discovery.
The team additionally discovered that NK cells can be modified to mimic the metabolism of tumors. The modified NK cells proved to be far better adapted for the hostile tumor environment.
This is the first report of an anti-tumor immune cell that exploits the hostility of tumors for their own advantage.
So far, NK cells have only proven effective against blood cancers. The re-programmed and trained NK cells could mean patients with otherwise terminal cancers may have a safe and effective treatment option.
Lung and ovarian cancer are two examples of cancers whose survival rates have remained low over the last 30 or so years.
If you care about cancer, please read studies about this stuff in the mouth could lead to oral cancer and findings of this depression drug may stop cancer growth.
For more information about cancer treatment and prevention, please see recent studies about common cholesterol-lowering drugs may do double duty on cancer and heart disease and results showing that this drug can give the immune system a double boost against cancer.
The study is published in Cell Metabolism. One author of the study is Ali Ashkar.
Copyright © 2021 Knowridge Science Report. All rights reserved.
